Arbor Biotechnologies
Cambridge · Founded 2016
About Arbor Biotechnologies
Arbor Biotechnologies is a biotechnology company specializing in next-generation gene editing therapeutics to treat genetic diseases. The company utilizes artificial intelligence and high-throughput screening to discover and optimize novel gene-editing systems. Its research focuses on expanding the CRISPR-based gene editing toolbox for therapeutic applications. Arbor aims to develop treatments for rare and complex diseases by engineering precise and efficient genetic modifications.
Company Facts
- Founded: 2016
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $304.5M
- Funding stage: Late Stage Venture
- Last round: Series C (Mar 2025)
- Website: https://arbor.bio
- Phone: 857 301 6366
Industries & Categories
Artificial Intelligence (AI), Biopharma, Biotechnology, Life Science
Social Profiles
Canonical: https://fsome.com/organization/arbor-biotechnologies-84605 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.